Detalles de la búsqueda
1.
Personalizing age of gastric cancer screening based on comorbidity in China: Model estimates of benefits, affordability and cost-effectiveness optimization.
Prev Med
; 179: 107851, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191061
2.
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study.
BMC Med
; 21(1): 277, 2023 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501074
3.
Trametinib for patients with recurrent low-grade serous ovarian cancer: A cost-effectiveness analysis.
Gynecol Oncol
; 168: 17-22, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368128
4.
Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019.
World J Urol
; 41(12): 3629-3634, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37831157
5.
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma.
BMC Health Serv Res
; 23(1): 49, 2023 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653848
6.
First-line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non-small cell lung cancer: A United States-based cost-effectiveness analysis.
Cancer
; 125(20): 3526-3534, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31287562
7.
NNN Pincer Ru(II)-Complex-Catalyzed α-Alkylation of Ketones with Alcohols.
J Org Chem
; 83(7): 3657-3668, 2018 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29533663
8.
Ordering kinetics of lamella-forming block copolymers under the guidance of various external fields studied by dynamic self-consistent field theory.
Phys Chem Chem Phys
; 19(9): 6707-6720, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28210724
9.
First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.
PLoS One
; 18(4): e0279786, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37053300
10.
Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis.
J Infect Public Health
; 16(6): 893-900, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062164
11.
Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States.
Clin Ther
; 45(10): 965-972, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537015
12.
Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients With Large Unresectable Hepatocellular Carcinoma.
Front Pharmacol
; 13: 849189, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35559260
13.
Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis.
Front Pharmacol
; 13: 1003483, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36339555
14.
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA.
Adv Ther
; 39(10): 4583-4593, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943715
15.
Cost-effectiveness analysis of tislelizumab, nivolumab and docetaxel as second- and third-line for advanced or metastatic non-small cell lung cancer in China.
Front Pharmacol
; 13: 880280, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36091746
16.
Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell Lung Cancer.
Front Pharmacol
; 13: 832215, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35517823
17.
Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review.
Front Pharmacol
; 13: 860109, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35496294
18.
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer.
Front Pharmacol
; 13: 881787, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35712723
19.
Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Front Pharmacol
; 13: 778505, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35222020
20.
Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis.
Clin Rheumatol
; 41(1): 63-73, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373933